Stock Price Quote

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC
BSE1084.003.75 (+0.35 %)
PREV CLOSE ( ) 1080.25
OPEN PRICE ( ) 1076.00
BID PRICE (QTY) 1080.20 (8)
OFFER PRICE (QTY) 1084.00 (129)
VOLUME 6512
TODAY'S LOW / HIGH ( )1076.00 1089.00
52 WK LOW / HIGH ( )599.95 1224
NSE672.250 (0 %)
PREV CLOSE( ) 672.25
OPEN PRICE ( ) 691.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 672.25 (249)
VOLUME 11837
TODAY'S LOW / HIGH( ) 668.35 698.20
52 WK LOW / HIGH ( )668.35 909
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-12 1947
Management Info
C Snook - Chairman Sanjay Murdeshwar - Managing Director
Registered Office

Address The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra East,
Mumbai,
Maharashtra-400051

Phone 022-50243000

Email india.investors@novartis.com

Website www.novartis.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

15May Novartis India informs about loss of s
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
10May Novartis India informs about board mee
In continuation to intimation dated March 27, 2024 and pursuant to Regul..
08May Novartis India informs about change in
Novartis India has informed that based on the recommendation of Nominati..
08May Appointment of Company Secretary and
Appointment of Company Secretary and Compliance officer in Novartis Indi..
19Mar Novartis India informs about details o
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit146.8851.9
Gross Profit 213.3 1228.4
Operating Profit 216.31269.4
Net Sales 811.73350.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thacker & Co (BSE)
peergroup  1065.00 (4.08%)
M.Cap ( in Cr)115.72
Meson Valves India (BSE)
peergroup  1239.00 (3.41%)
M.Cap ( in Cr)1257.82
Adani Enterprises (BSE)
peergroup  3257.65 (1.04%)
M.Cap ( in Cr)369451.56
India Motor Parts (BSE)
peergroup  1067.00 (2.91%)
M.Cap ( in Cr)1329.87
Veritas (India) (BSE)
peergroup  1157.75 (2.00%)
M.Cap ( in Cr)3101.92

Shareholding Pattern

PROMOTERS 70.68%
NON-INSTITUTION 28.61%
FI/BANKS/INSURANCE 0.52%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Novartis India Ltd.

Novartis India Ltd. was incorporated in the year 1947. Its today's share price is 1084. Its current market capitalisation stands at Rs 2681.3 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4598.6 Cr and Total Income of Rs.4368.5 Cr. The company's management includes Chandni Maru, Gira Sardesai, Shilpa Joshi, Sanker Parameswaran, Sandra Martyres, Sanjay Murdeshwar, C Snook.

It is listed on the BSE with a BSE Code of 500672 , NSE with an NSE Symbol of NOVARTIND and ISIN of INE234A01025. It's Registered office is at The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra EastMumbai-400051, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AF Ferguson & Co, BSR & Co LLP, Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.